首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2547篇
  免费   129篇
  国内免费   94篇
耳鼻咽喉   54篇
儿科学   72篇
妇产科学   106篇
基础医学   208篇
口腔科学   117篇
临床医学   235篇
内科学   586篇
皮肤病学   98篇
神经病学   126篇
特种医学   172篇
外科学   500篇
综合类   109篇
预防医学   50篇
眼科学   55篇
药学   129篇
中国医学   4篇
肿瘤学   149篇
  2023年   19篇
  2022年   22篇
  2021年   34篇
  2020年   33篇
  2019年   52篇
  2018年   57篇
  2017年   57篇
  2016年   81篇
  2015年   81篇
  2014年   104篇
  2013年   133篇
  2012年   172篇
  2011年   175篇
  2010年   111篇
  2009年   114篇
  2008年   145篇
  2007年   248篇
  2006年   183篇
  2005年   168篇
  2004年   126篇
  2003年   98篇
  2002年   76篇
  2001年   50篇
  2000年   57篇
  1999年   37篇
  1998年   29篇
  1997年   33篇
  1996年   36篇
  1995年   22篇
  1994年   11篇
  1993年   22篇
  1992年   7篇
  1991年   10篇
  1990年   4篇
  1989年   17篇
  1988年   6篇
  1987年   13篇
  1986年   9篇
  1985年   16篇
  1983年   7篇
  1982年   9篇
  1981年   11篇
  1980年   7篇
  1978年   5篇
  1977年   8篇
  1976年   5篇
  1975年   6篇
  1973年   4篇
  1972年   5篇
  1970年   5篇
排序方式: 共有2770条查询结果,搜索用时 0 毫秒
61.
62.
Jacobs  P; King  HS 《Blood》1987,69(6):1642-1646
One hundred eight consecutive patients with indolent lymphoproliferative diseases were stratified into chronic lymphocytic leukemia (CLL), stage III and IV well-differentiated lymphocytic lymphoma (WDLL), and stage III and IV follicular lymphoma (FL). Within each stratum, patients were prospectively and randomly assigned to receive chemotherapy with chlorambucil and prednisone (CP) or fractionated total body irradiation (TBI). Morbidity from both regimens was negligible. Complete response (CR) was defined as the resolution of organ enlargement and the return of blood count to normal. The CR rate for the entire CP group (n = 54) was 59% and that for the TBI group (n = 54), 52%; median survivals were 53 and 57 months respectively. In the 41 patients with CLL the CR rate for CP (n = 17) was 47% and that for TBI (n = 24), 50%; the median survival for CP was 48 months, and for TBI it was 51 months. In the 21 patients with WDLL the CR rate for CP (n = 15) was 53% and that for TBI (n = 6), 67%; the median survival for CP was 42 months and has not yet been reached for TBI. For the 46 patients with FL the CR rate for CP (n = 22) was 72% and that for TBI (n = 24), 50%; the median survival was 55 months, and for TBI it was 56 months. None of the differences in CR or survival are statistically significant (P greater than .05). In these indolent lymphoproliferative diseases, CP and TBI are equally effective forms of initial treatment irrespective of the end point being defined as CR or survival.  相似文献   
63.
64.
65.
66.

Background

Intragastric band migration is an unusual but major complication of gastric banding. We review our experience with endoscopic removal of eroded gastric bands.

Methods

We retrospectively evaluated the cases of 110 morbidly obese patients who underwent adjustable gastric banding between 2005 and 2012 to identify those who experienced band erosion. To remove the migrated band, we used an endoscopic approach with a Gastric Band Cutter.

Results

Band or tube erosion occurred in 14 patients (12.7%). The median time interval from the initial gastric band placement to the diagnosis of band erosion was 32 (range 18–52) months. Upper abdominal pain, port site infection, loss of restriction and weight regain were the most common symptoms. We used the Gastric Band Cutter to remove the band endoscopically. It was able to cut the band successfully in all but 1 patient, in whom twisting of the cutting wire required conversion from endoscopy to laparotomy. In 2 patients, the band, after being cut, was locked in the gastric wall and required laparotomic removal. In 1 patient, we performed surgery for intragastric penetration of the connecting tube broken close to the band.

Conclusion

The Gastric Band Cutter was successful in dividing the band in all but 1 patient, although we could not always complete the procedure endoscopically. Endoscopic removal seems to be effective and safe for band erosion.  相似文献   
67.
68.
69.
70.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号